Job Overview


Become a part of the Department that touches the lives of every American.  At the Department of Health and Human Services (HHS), you can give back to your community, state and country by making a difference in the lives of Americans everywhere.  It is the principal agency for protecting the health of citizens.  Join HHS and help to make our world healthier, safer and better for all Americans.

These vacancies will be filled through OPM's Direct Hire Authority. Veterans' preference and traditional rating and ranking of applicants does not apply to positions filled under this announcement.

1st Cut-Off Date: 4/18/13; 2nd Cut-Off Date: 5/2/13; 3rd Cut-Off Date: 5/16/13; 4th Cut-Off Date: 5/30/13; 5th Cut-Off Date: 6/13/13; 6th Cut-Off Date: 6/27/13

This announcement is being used to create an inventory of qualified applicants for Pharmacists positions and will be used to fill immediate and future vacancies. 

Applications received as a result of job fairs, recruitment events, and emergency hiring mechanisms in support of this hiring initiative will also be accepted during the duration of the Direct Hire Authority.

These positions are located in one of the Divisions in the Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, MD.

Additional selections may be made within the same geographical area HHS-wide.


Major Duties:

Reviews, evaluates, interprets, analyzes, and abstracts pertinent adverse drug reaction reports in the Adverse Events Reports Systems (AERS). 
Utilizes the medical-scientific judgment in determining the adequacy of clinical documentation, the severity of the adverse reaction, and the possible causal relationship between specific therapeutic agents and the adverse reaction. 
Prepares summaries describing clinical assessment of adverse reaction analyses. 
Contributes to the development and improvement of procedures for post-marketing surveillance and the processing and evaluation adverse drug product reaction reports. 
Keeps abreast of new developments in drug products and their applications in order to anticipate possible safety and reporting problems.